Download FREE Report Sample
Download Free samplePeople with iron deficiency and mild to moderate anemia are mainly treated with oral iron, and their diets should be improved to eat iron-rich foods. Severe anemia can be treated with oral iron or intravenous iron, as well as a small number of repeated infusions of packed red blood cells. However, intravenous iron supplementation is not recommended during the first trimester.
Iron Deficiency Anemia Treatment Market contains market size and forecasts of Iron Deficiency Anemia Treatment in global, including the following market information:
Global Iron Deficiency Anemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Iron Deficiency Anemia Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Iron Deficiency Anemia Treatment companies in 2021 (%)
The global Iron Deficiency Anemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ferrous Sulfate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Iron Deficiency Anemia Treatment include AdvaCare Pharma, Akorn, Sun Pharmaceutical Industries Ltd., Akebia Therapeutics, Inc., Rockwell Medical, Inc., Vifor Pharma Management Ltd., Shield Therapeutics, AMAG Pharmaceuticals and Pharmacosmos A/S. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Iron Deficiency Anemia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Iron Deficiency Anemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Iron Deficiency Anemia Treatment Market Segment Percentages, by Type, 2021 (%)
Ferrous Sulfate
Ferrous Gluconate
Ferrous Fumerate
Ferric Hydroxide
Sodium Ferric Gluconate
Iron Carbohydrates
Others
Global Iron Deficiency Anemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Iron Deficiency Anemia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Iron Deficiency Anemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Iron Deficiency Anemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Iron Deficiency Anemia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Iron Deficiency Anemia Treatment revenues share in global market, 2021 (%)
Key companies Iron Deficiency Anemia Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Iron Deficiency Anemia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AdvaCare Pharma
Akorn
Sun Pharmaceutical Industries Ltd.
Akebia Therapeutics, Inc.
Rockwell Medical, Inc.
Vifor Pharma Management Ltd.
Shield Therapeutics
AMAG Pharmaceuticals
Pharmacosmos A/S
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy